✦ LIBER ✦

PDB46 COST-EFFECTIVENESS OF NEW ANTIDIABETICS IN TYPE 2 DIABETES: A REVIEW

✍ Scribed by S Baytar; S Malhan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB6 PREVENTION OF TYPE 2 DIABETES IN TH

✍ AJ Palmer; S Roze 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

PDB27 THE COST-EFFECTIVENESS OF INSULIN

✍ J Walczak; W Dardzinski; M Kusy; J Lis; G Nogas 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB

PDB28 THE COST-EFFECTIVENESS ANALYSIS OF

✍ J Walczak; G Nogas; E Gebus; D Pawlik; K Pacocha 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PDB53 Cost-Effectiveness of Saxagliptin

✍ A. Juarez-Garcia; D. Casalvolone; L. Qatami; K. Bergenheim; B.M.K. Donato 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

Cost-effectiveness of screening for type

✍ Haykal, D.; Martínez, L. 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 56 KB

PDB18 COST-EFFECTIVENESS OF ACARBOSE IN

✍ T Evers; S Roze; AJ Palmer; WJ Valentine; D Tucker; M Hanefeld 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 63 KB